Illness	Number of cases
Lymphoid leukaemia - Acute lymphoblastic leukemia not having achieved remission (C91.00)	143
Type 1 diabetes mellitus without complications (E10.91)	109
Diarrhoea and gastroenteritis of presumed infectious origin (A09.9)	94
Acute bronchitis - Acute bronchitis unspecified (J20.9)	93
Acute tubulo-interstitial nephritis (N10)	88
Viral pneumonia not elsewhere classified - Respiratory syncytial virus pneumonia (J12.1)	74
Malignant neoplasm of bone and articular cartilage of limbs (C40.2)	64
Epilepsy (G40.3)	64
Acute upper respiratory infections of multiple and unspecified sites (J06.8)	57
Convulsions not elsewhere classified (R56.8)	57

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	2.337
(9-985.0)	1.681
(8-01a)	1.349
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	826
Measurement of the brain waves - EEG (1-207.0)	776
Others therapeutic procedures to influence the immune system (8-547.31)	474
Examination of the cerebrospinal fluid spaces (1-204.2)	361
(1-999.3)	354
Patient education (9-500.0)	353
Measurement of the brain waves - EEG (1-207.1)	314

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1000 , 0510

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ05
CQ02

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
197	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
132	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
129	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre Phase I/II studies
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks
Project-related cooperation with colleges and universities
Doctoral supervision
Lectureships / teaching posts at colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Lectureships / teaching posts at universities of applied sciences
Participation in multi-centre phase III/IV studies

Training

No.	Training in other healing professions	Comment
HB20	Nursing professional B. Sc.	In Kooperation mit Münchner Hochschulen
HB19	Nursing professionals	384 Plätze
HB17	Auxiliary nurse (m/f)	Wir bilden Pflegefachhelfer*innen aus (50 Plätze).
HB15	Anaesthesia technical assistant (m/f)	96 Plätze OTA und ATA
HB07	Surgical technical assistant (m/f)	96 Plätze OTA und ATA